IL18BP
protein-codinginterleukin 18 binding protein, the group of Immunoglobulin like domain containing
Gene summary
The protein encoded by this gene functions as an inhibitor of the proinflammatory cytokine, IL18. It binds IL18, prevents the binding of IL18 to its receptor, and thus inhibits IL18-induced IFN-gamma production, resulting in reduced T-helper type 1 immune responses. This protein is constitutively expressed and secreted in mononuclear cells. Elevated level of this protein is detected in the intestinal tissues of patients with Crohn's disease. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032809
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0032809
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: The condition has been described as involving susceptibilty to fulminant viral hepatitis as well as other autoimmune manifestations, and awareness may allow prompt and aggressive management of infectious and related sequelae
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IL18BP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001039660.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 29 | 1 | 42 | ||
| missense | 89 | 5 | 3 | 97 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 5 | 5 | ||||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 0 | 0 | 118 | 34 | 4 | 156 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001034749.1 | 5 | MANE Select | |
| Ensembl | ENSP00000377306.4 | 5 | MANE Select | |
| RefSeq | NP_001034748.1 | 5 | Standard | |
| RefSeq | NP_001138527.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Signaling by Interleukins
- Cytokine Signaling in Immune system
- Interleukin-18 signaling
- Purine metabolism
- Immune System
Biological Process
- response to lipopolysaccharide
- interleukin-18-mediated signaling pathway
- T-helper 1 type immune response
- cellular response to hydrogen peroxide
- cellular response to cytokine stimulus
Molecular Function
- interleukin-18 binding
- receptor antagonist activity
Cellular Component
- extracellular region
- extracellular space
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000404792
- Coding exons
- 5
- Length
- 7175
- Individuals with no LoFs
- 124749
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 56
- Defined
- 124805
- p
- 0.000224
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.554 | 126 | 110 | 1.15 | 0.00000626 | 1229 |
| Missense (PolyPhen) | 31 | 22.579 | 1.373 | 293 | ||
| Synonymous | -0.749 | 54 | 47.4 | 1.14 | 0.00000272 | 414 |
| Loss of Function | -0.541 | 11 | 9.23 | 1.19 | 4.79e-7 | 95 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000065 | 0.000065 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0010 | 0.0010 | notable |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00014 | 0.00014 | rare |
| South Asian | 0.00060 | 0.00056 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform A binds to IL-18 and inhibits its activity. Functions as an inhibitor of the early TH1 cytokine response. {ECO:0000269|PubMed:10023777, ECO:0000269|PubMed:10655506}.;
Recessive Scores
- pRec
- 0.0732
Intolerance Scores
- LoFtool
- 0.645
- RVIS EVS
- 0.26
- RVIS percentile EVS
- 70.26
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |